Vyjuvek Kit
Product Images NDC 82194-510

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Vyjuvek (NDC 82194-510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Krystal Biotech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

The text is a medication label for Amoxy containing instructions for use, dosage, preparation, and administration. It comes in single-use vials and requires thawing and mixing before administration. The medication should be stored in a frozen state and must be kept between 5 °C and 25 °C. It contains specific chemical compounds and no preservatives. The medication label is intended for topical use only and is manufactured in the United States by KrysalBotech Inc. The label provides the necessary information for dosage, preparation, and administration.*

FDA Label Image

Fig1 (Fig1)

FDA Label Image

Fig10 (Fig10)

The text describes a figure (Figure 10) illustrating the process of disconnecting an administration syringe containing VYJUVEK gel. The image shows an air pocket visible in the syringe.*

FDA Label Image

Fig11 (Fig11)

The text describes a figure (Figure 11) that demonstrates how to manipulate an administration syringe plunger to remove air pockets.*

FDA Label Image

Fig12 (Fig12)

FDA Label Image

Fig13 (Fig13)

The text describes a figure depicting the process of connecting an administration syringe to the needle within an excipient gel vial stopper.*

FDA Label Image

Fig14 (Fig14)

The text describes an image or figure numbered 14 that shows the application of VYJUVEK gel to a wound.*

FDA Label Image

Fig15 (Fig15)

This text is describing an image or a step in a process where a non-adherent hydrophobic dressing is being placed over a treated wound.*

FDA Label Image

Fig16 (Fig16)

FDA Label Image

Fig2 (Fig2)

This is a description of a figure showing a timelapse of an excipient gel thawing from 0 minutes to 20 minutes. There is no additional information available.*

FDA Label Image

Fig3 (Fig3)

The image shows a syringe being used to remove 1 milliliter of a biological suspension.*

FDA Label Image

Fig4 (Fig4)

The text describes a figure numbered as 4 that shows the process of transferring a biological suspension named VYJUVEK to an excipient gel vial.*

FDA Label Image

Fig5 (Fig5)

FDA Label Image

Fig6 (Fig6)

This text describes a step-by-step process for an unknown activity or experiment involving a plunger and a measurement mark of 1 mL. The activity requires the user to pull the plunger back to the 1 mL mark to remove air.*

FDA Label Image

Fig7 (Fig7)

FDA Label Image

Fig8 (Fig8)

FDA Label Image

Fig9 (Fig9)

The text describes a figure labeled as number 9, which shows an administration syringe withdrawing 0.4 mL of VYJUVEK gel while an air pocket is visible.*

FDA Label Image

Vial 001-01 (Vial00101)

FDA Label Image

Vial 510-01 (Vial51001)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.